Sign in

Trial site

Institutul Privat de Cercetări Melchisedec pentru Boli Autoimune, Ereditare și Rare -I.P.C.M

Craiova, 200157, RomaniaEU-13 widening countryNot linked to an institution yet
  • 2running trials

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions
Phase
  • Phase 33 trials
  • Early phase 11 trial
Status
  • Recruiting2 trials
  • Suspended2 trials
Lead sponsor
  • Karuna Therapeutics, Inc., a Bristol Myers Squibb company2 trials
  • Massachusetts General Hospital1 trial
  • Xenon Pharmaceuticals Inc.1 trial

Running trials

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

Site data: ClinicalTrials.govUpdated 18 Nov 2026

Institutul Privat de Cercetări Melchisedec pentru Boli Autoimune, Ereditare și Rare -I.P.C.M: trial site – Frontlight Research